Decentralized Heart Failure Management in Neno, Malawi

Bright G D Mailosi1, Todd Ruderman1, Sheila L Klassen2,3,4

  • 1Partners In Health/Abwenzi Pa Za Umoyo, Neno, Malawi.

Global Heart
|June 19, 2023
PubMed

Insights

In rural Malawi, non-physician providers successfully used focused cardiac ultrasound (FOCUS) to diagnose and manage heart failure (HF), improving patient outcomes. This model shows promise for expanding healthcare access in resource-limited African settings.

Area of Science:

  • Cardiology
  • Public Health
  • Global Health

Background:

  • Cardiovascular disease (CVD) is a leading cause of mortality in Malawi.
  • Heart failure (HF) care in rural Malawian districts is scarce and primarily managed by non-physicians.
  • The specific causes and patient outcomes of HF in rural African populations remain largely uncharacterized.

Purpose of the Study:

  • To describe the clinical characteristics, HF diagnostic categories, and patient outcomes in a rural Malawian setting.
  • To evaluate the effectiveness of focused cardiac ultrasound (FOCUS) performed by non-physician providers for HF diagnosis and management.
  • To assess the impact of this care model on patient symptoms and clinical status.

Main Methods:

  • Non-physician healthcare providers utilized FOCUS for HF diagnosis and longitudinal follow-up in an outpatient chronic disease clinic in Neno, Malawi, from November 2018 to March 2021.
  • A retrospective chart review analyzed HF diagnostic categories, changes in clinical status, and outcomes.
  • Cardiologists reviewed all available ultrasound images for diagnostic confirmation.

Main Results:

  • The study included 178 patients with HF (median age 67 years, 58% women), with a mean follow-up of 11.5 months; 78% were alive and receiving care.
  • Hypertensive heart disease (36%), cardiomyopathy (26%), and rheumatic/valvular/congenital heart disease (12.3%) were the most common HF causes identified by ultrasound.
  • At follow-up, the proportion of patients in New York Heart Association (NYHA) class I significantly increased from 24% to 50% (p < 0.001), with decreased symptoms of fluid overload and fatigue.

Conclusions:

  • Hypertensive heart disease and cardiomyopathy are the primary drivers of HF in this elderly rural Malawian cohort.
  • Trained non-physician providers can effectively manage HF, leading to improved symptoms and clinical outcomes in resource-limited settings.
  • This care model offers a scalable solution to enhance healthcare accessibility for HF patients in other rural African regions.
Abstract

Related Concept Videos

Heart Failure V: Medical Management01:30

Heart Failure V: Medical Management

Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
16
Heart Failure VII: Nursing Interventions01:30

Heart Failure VII: Nursing Interventions

The first step in nursing management of a patient with heart failure involves thoroughly assessing the patient's medical history.Subjective Data: Obtain the patient's medical history of coronary artery disease, hypertension, myocardial infarction, and symptoms like dyspnea, orthopnea, and paroxysmal nocturnal dyspnea.Objective Data: Conduct a physical examination to identify findings such as jugular vein distention, pulmonary crackles, tachycardia, murmurs, peripheral edema, and vital signs,...
118
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
469
Cardiomyopathy VI: Nursing Management01:29

Cardiomyopathy VI: Nursing Management

Assessment: Nursing management of patients with cardiomyopathy begins with a thorough assessment of the patient's history, including a family history of cardiomyopathy or sudden cardiac death, personal history of heart disease, hypertension, diabetes, and any alcohol consumption or drug use.During the physical examination, assess vital signs, look for signs of heart failure (such as edema, jugular venous distention, and cyanosis), auscultate for abnormal heart sounds (like murmurs and gallops),...
16
Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
17
Rheumatic Heart Disease IV: Nursing Management01:20

Rheumatic Heart Disease IV: Nursing Management

AssessmentA comprehensive assessment is essential in managing a patient with rheumatic heart disease (RHD). Begin with obtaining a detailed medical history, including recent streptococcal infections, a history of rheumatic fever, or previously diagnosed rheumatic heart disease. Assess the patient for symptoms such as fever, chest pain, widespread joint pain (arthralgia), tachycardia, pericardial friction rub, muffled heart sounds, heart murmurs, peripheral edema, subcutaneous nodules, and...
23